InvestorsHub Logo
Followers 55
Posts 2608
Boards Moderated 0
Alias Born 02/04/2014

Re: urup post# 33454

Sunday, 03/29/2015 12:18:04 PM

Sunday, March 29, 2015 12:18:04 PM

Post# of 144817
I am really interested to hear about the clinical studies and why they are doing two different trials. It appears the first will address just pain associated with pancreatic cancer and is most likely why we applied with the FDA for ODD for pancreatc cancer only.

The second will address malignant ascites which will aid all abdominal cancers. This second study is also for a treatment that no one else has. There is no other treatment for malignant ascites.

Interesting and thanks for making DD easier for investors by providing all your great posts.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News